J Frontier Co., Ltd. (2934) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for J Frontier Co., Ltd. (2934:JPX), powered by AI.

Current Price
¥1,467
P/E Ratio
84.2
Market Cap
7.4B
Sector
Healthcare
What is the J Frontier Co., Ltd. stock price forecast?

J Frontier Co., Ltd. is currently trading at ¥1,467. View real-time AI analysis on Alpha Lenz.

What is J Frontier Co., Ltd. insider trading activity?

View the latest insider trading data for J Frontier Co., Ltd. on Alpha Lenz.

What is J Frontier Co., Ltd.'s P/E ratio?

J Frontier Co., Ltd.'s P/E ratio is 84.2.

J Frontier Co., Ltd.

JPX · 2934
¥1,467+9(+0.62%)Market closedJPX regular session 09:00–15:00 JST
Ask about J Frontier Co., Ltd.'s future dividend policy...
Alpha Chat Insight

J Frontier Co., Ltd. trades at a P/E of 84.2 (premium valuation) with modest ROE of 6.9%. 3Y revenue CAGR of 21.9% highlights clear growth momentum.

Ask for details

Company Overview

J Frontier Co., Ltd. is a Japanese company primarily engaged in the development and operation of e-commerce services. Its main focus is on healthcare and beauty products, catering to the growing online marketplace in Japan and potentially beyond. J Frontier Co., Ltd. operates platforms that facilitate the purchase of pharmaceuticals and healthcare products, aiming to enhance the consumer experience by offering a wide selection of goods in a convenient online format. This positions the company well within the health and wellness sector, which is seeing increasing demand due to global trends in healthy living and aging populations. J Frontier also uses strategic partnerships to expand its product base and enhance its market reach. In the financial market, J Frontier Co., Ltd. represents an opportunity to engage with the expanding digital retail landscape, while also underlining the rising significance of e-commerce in meeting consumer needs. The company’s focus on leveraging technology to meet the evolving demands of consumers underscores its role as a forward-looking participant in the online healthcare and beauty industry.

CEOMr. Atsuhiro Nakamura
SectorHealthcare
IndustryPharmaceutical Retailers
Employees202

Company Statistics

FY 2025

Profile

¥7,374,579,660Market Cap
¥21,504,496,000Revenue
0.00Shares Out
202Employees

Margins

44.52%Gross
4.11%EBITDA
1.37%Operating
1.16%Pre-Tax
0.61%Net

Valuation

84.21P/E
5.24P/B
0.34EV/Sales
11.49EV/EBITDA
16.49P/FCF

Growth (CAGR)

21.88%Rev 3Yr
24.79%Rev 5Yr
-26.21%Op Inc 3Yr
11.51%Op Inc 5Yr
-30.94%Net Inc 3Yr
6.47%Net Inc 5Yr

Returns

1.28%ROA
6.88%ROE
2.99%ROIC

Financial Health

¥2,169,645,000Cash & Cash Equivalents
¥4,988,861,000Net Debt
355.39%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

J Frontier Co., Ltd. (ticker: 2934) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 202 employees. Market cap is $7.4B.

The current price is 1,467 with a P/E ratio of 84.21x and P/B of 5.24x.

ROE is 6.88% and operating margin is 1.37%. Annual revenue is $21.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
J Frontier Co., Ltd. (2934) Stock Forecast 2026 ¥1,467 — Price, Financials & Analyst Targets | Alpha Lenz